MyFoot Diabetic Shoes are engineered around the biomechanical and clinical needs of the diabetic foot, with a primary focus on pressure redistribution, friction reduction, accommodation, stability, and protection.
Diabetes is frequently associated with peripheral neuropathy and impaired peripheral circulation. Peripheral neuropathy means that the nerves in the feet can become damaged, reducing the ability to feel pain, heat, pressure, or minor injuries.
Impaired circulation means that blood flow to the feet may be reduced, which can make wounds more difficult to heal. As a result, a small blister, cut, or pressure point may go unnoticed and potentially develop into a diabetic foot ulcer or infection.
For this reason, appropriate footwear is an important part of reducing avoidable mechanical stress on the diabetic foot.
MyFoot incorporates a rocker sole geometry designed to reduce peak plantar pressure and facilitate smoother forward progression during gait.
In simpler terms, the curved sole helps the foot roll forward more naturally during walking and can reduce the highest-pressure points underneath the foot. This helps distribute loading over a larger area rather than concentrating excessive pressure in one specific location.
Construction is deliberately designed as a multi-layer system, combining cushioning with sufficient structural stability.
The midsole is lightweight but relatively firm and resilient. Its role is not simply to provide cushioning, but also to maintain the intended shape and geometry of the shoe during walking.
In particular, it helps the rocker profile retain its shape rather than deforming excessively under body weight. Maintaining this geometry is important because excessive deformation can change how pressure is distributed across the foot and reduce the effectiveness of the rocker design.
The firmer midsole also helps prevent the sole from progressively collapsing or losing its structural characteristics during long-term use. This provides more consistent mechanical performance throughout the life of the shoe.
The bottom sole uses a softer, more compliant material to provide cushioning and help absorb impact as the foot contacts the ground.
Together with the midsole, this construction helps attenuate impact and distribute forces more evenly, reducing mechanical stress on sensitive areas of the foot.
Importantly, maximum softness is not necessarily the same as optimal protection. While an extremely soft sole may initially feel very comfortable, excessive softness or instability can allow the foot to move excessively within the shoe.
Depending on the individual's biomechanics, this may contribute to increased pronation or supination — meaning excessive inward or outward movement of the foot during loading. For a diabetic foot, controlling unnecessary movement and maintaining predictable load distribution can be just as important as providing cushioning.
MyFoot therefore aims to achieve a balance between cushioning, pressure reduction, and mechanical stability, rather than simply making the sole as soft as possible.
The lining system is also specifically engineered for the needs of sensitive feet.
The inner lining combines soft moleskin with a pressure-responsive spacer foam, creating a smooth and cushioned interface between the foot and the shoe.
The moleskin provides a soft, low-friction surface against the skin, while the spacer foam adds cushioning and helps the lining conform to the individual contours of the foot.
The spacer foam has viscoelastic, memory-like properties. When pressure is applied, the foam gradually compresses and adapts to the shape of the foot rather than behaving like a rigid material that immediately pushes back against areas of higher pressure.
When the pressure is reduced or removed, the foam gradually recovers toward its original shape.
This gradual response allows the lining to continuously adapt to changes in the foot's contours and pressure distribution during use, while helping to avoid unnecessary counter-pressure.
In practical terms, the foam can accommodate areas such as the toes, metatarsal region, bunions, or other anatomical prominences instead of forcing the foot to conform to a fixed internal shape.
The result is a softer and more adaptive contact surface that helps spread localized pressure over a larger area and reduce friction and concentrated pressure points — particularly important for people with diabetic neuropathy, who may have reduced awareness of excessive pressure or irritation.
The upper is specifically designed to minimize external pressure and friction. Extra depth and a wide toe box provide additional space for swelling, changes in foot shape, deformities, and custom orthotic devices.
This prevents the shoe from squeezing the toes or pressing against areas that may already be vulnerable.
Seamless internal construction minimizes internal friction and eliminates prominent seams that can rub against the skin. This is particularly important for people with reduced sensation, who may not notice irritation until skin damage has already occurred.
MyFoot uses soft, stretchable and non-binding materials that adapt to the shape of the foot instead of creating rigid pressure points. This is especially useful around areas such as the toes, bunions, and other anatomical prominences.
Adjustable closures, including laces and Velcro systems, allow the fit to be modified throughout the day to accommodate changes in foot volume and swelling.
Beyond the overall geometry and materials of the shoe, MyFoot incorporates a number of specific construction details designed to reduce unnecessary pressure, friction, and mechanical stress while maintaining appropriate stability and ease of use.
The toe puff, the structural reinforcement at the front of the shoe, is intentionally kept as short as practical. This reduces the amount of rigid material extending over the forefoot and helps minimize contact and pressure on the toes during walking.
The design provides the necessary structural support for the upper while allowing greater freedom and accommodation around the toes.
The heel counter is designed to be slightly higher and longer than a conventional soft shoe counter in order to provide sufficient rearfoot stability and help maintain the foot in a consistent position within the shoe.
At the same time, the counter is constructed with consideration for the sensitivity of the heel area, avoiding unnecessary rigidity or excessive pressure.
The heel counters are made from a thermoplastic material that can be heat-molded when required. This allows the counter to be further adapted to the individual shape of the foot, helping to reduce localized pressure, unwanted contact, and friction around the heel.
This adjustability is particularly useful when anatomical variations or prominent areas require additional accommodation.
All zippers are equipped with large, easy-to-grip pullers. This facilitates opening and closing of the shoe for users who may have reduced finger sensitivity, limited dexterity, or difficulty manipulating small conventional zipper pulls.
The larger puller provides a more accessible point of contact and can make independent use of the footwear easier.
The Velcro fastening systems incorporate stoppers designed to prevent the fastening strap from unintentionally sliding out of its guiding roller.
This helps keep the closure system properly positioned during repeated opening and closing and supports consistent adjustment of the shoe.
Together, these construction details complement the broader design principles of the MyFoot Diabetic Shoe by addressing not only pressure and cushioning, but also the practical mechanical interaction between the shoe and the foot.
The objective is to provide appropriate accommodation and stability while minimizing unnecessary contact, friction, compression, and difficulties in everyday use.
MyFoot has developed and clinically evaluated these design principles in collaboration with specialized physicians and experts in orthopedic footwear.
The aim is to combine clinical knowledge, biomechanical principles, and practical footwear engineering to address the specific mechanical challenges associated with the diabetic foot.
The result is a footwear system designed not simply for comfort, but to address several important mechanical risk factors: excessive plantar pressure, friction, compression, impact, restricted toe space, changes in foot volume, and excessive or uncontrolled foot movement.
In short, every major element of the MyFoot Diabetic Shoe — from the rocker sole and stable midsole to the soft adaptive lining, seamless interior, and spacious toe box — is designed to help protect the foot from mechanical stresses that may otherwise go unnoticed.
